What is the diffrence in japan mkt requirement in analytical method validation over US?
Answer / Ganesh Prasad
The differences between Japan and US market requirements for analytical method validation primarily lie in regulatory guidelines and standards. The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has its own guidelines such as 'Guideline on Pre-clinical Safety Studies' and 'Guideline on Good Clinical Practice'. On the other hand, the US Food and Drug Administration (FDA) follows Title 21 of the Code of Federal Regulations (CFR) Parts 58 and 600 for method validation. Additionally, there might be variations in acceptance criteria, like precision, accuracy, specificity, and robustness based on regional guidance documents.
| Is This Answer Correct ? | 0 Yes | 0 No |
Do you know what Trace metal clean technique is?describe that technique?
1 Answers Mylan, Nirma, Oil and Gas Jobs, Reddy Labs,
why we are taking 85 ml of concentrated HCl to prepare 1N Solution
How you start the method development of unknown compound.
why should we calibrate pH meter with 4,9.2 and 7.4 buffers particularly?
why we cannot analysis below 200nm in u.v?
if you have given one product then how you determine the impurity in that?
what is polarity and how to calculate
which solution used for detecting factor of k.f.titroter except water
what are the sources in ELSD,PDA, RI and UV Detectors?
Why we inject a standard 6 times for Related substances by HPLC and 5 times for Assay?
Why sometime potassium ortho phosphate mix with acetone use for sample preparation for hplc
WHICH STANDARD WE USE IN SILICA ANALYSIS IN SILICA-GEL METHOD FOR SOLID SAMPLE